AML Hub (@aml_hub) 's Twitter Profile
AML Hub

@aml_hub

A global education platform providing clinical updates on acute myeloid leukemia. #leusm
linktr.ee/AcuteMyeloidLe…

ID: 3289960226

linkhttp://www.aml-hub.com calendar_today24-07-2015 14:13:43

7,7K Tweet

8,8K Takipçi

2,2K Takip Edilen

AML Hub (@aml_hub) 's Twitter Profile Photo
AML Hub
@aml_hub

3 months ago

CONGRESS | #ASCO25 | POSTER Eunice Wang MD Roswell Park shares findings from a phase II study of olutasidenib in patients with R/R IDH1m AML who had received 1–2 (n = 93) or ≥3 (n = 54) prior treatment regimens. Patients with 1–2 prior regimens had a higher ORR and CR/CRh rate

CONGRESS | #ASCO25 | POSTER <a href="/EuniceWangMD/">Eunice Wang MD</a> <a href="/RoswellPark/">Roswell Park</a> shares findings from a phase II study of olutasidenib in patients with R/R IDH1m AML who had received 1–2 (n = 93) or ≥3 (n = 54) prior treatment regimens. Patients with 1–2 prior regimens had a higher ORR and CR/CRh rate